PMGC Holdings ELAB
NASDAQ ELAB
$3.36 +0.14 (+4.35%)
At close: Oct 2, 2026 · 4:00 PM EDT

PMGC Holdings (ELAB) Gains from Sales and Divestitures (2022 - 2026)

Updated

PMGC Holdings (ELAB) recorded Gains from Sales and Divestitures of $900.00 in Q2 2026.

Analysis

PMGC Holdings (ELAB) Gains from Sales and Divestitures (2022 - 2026) Analysis & Trends

On a TTM basis, PMGC Holdings' Gains from Sales and Divestitures came in at -$63,345 as of Jun 30, 2026; for FY2025, it was $129,613.

  • Across earlier years, Gains from Sales and Divestitures came in at -$1,546 in FY2022.
  • The Q2 2026 figure is the highest quarterly Gains from Sales and Divestitures since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 PMGC Holdings 1.64 Mn -46.72 Mn 385,691.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 900.00
Mar 31, 2026 -64,245.00
Mar 31, 2025 129,613.00
Dec 31, 2022 1.54 Mn
API Access

PMGC Holdings Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=ELAB&period=max&api_key=YOUR_API_KEY